Skip to main content
IMMUNOLOGY2026™ Main banner
Final Program


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Technical Innovations for Therapies

Saturday, April 18, 2026
12:45 PM - 2:15 PM US ET
Location: 151

Presentations:

  • 12:45 PM - 1:00 PM US ET
    Goal-oriented transgenic TCR-T cell design for efficient cancer immunotherapy

    Author: Sergey Panteleev, BS, MS (he/him/his) – Thomas Jefferson University

  • 1:00 PM - 1:15 PM US ET
    Generation and Performance of a DNA Barcode-Based Nuclear Receptor Reporter Library

    Author: Huijuan Yang, MS – Dartmouth Col.

  • 1:15 PM - 1:30 PM US ET
    Development of an in vitro Sjögren’s disease tissue chip for mechanistic studies and drug screening

    Author: Chiao Yun Chen (she/her/hers) – University of Rochester

  • 1:30 PM - 1:45 PM US ET
    A High-Throughput, Systems-based Neutralizing Antibody Assay Identifies Humoral Features Linked with Compartmentalized Neutralization

    Author: Qixin Wang, PhD – Harvard Univ. Chan Sch. of Pub. Hlth.

  • 1:45 PM - 2:00 PM US ET
    High-throughput TCR-epitope screening using the Jurkat NFAT Reporter-K562 APC cell system on the Microwell ELISpot Platform

    Author: Alex Chenchik, PhD (he/him/his) – Cellecta

  • 2:00 PM - 2:15 PM US ET
    Multi-omics profiling with InTraSeq™ uncovers novel single-cell RNA and Proteomics events in CARTs

    Author: Majd Ariss, PhD, MS – Cell Signaling Technology